Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T07:39:38.523Z Has data issue: false hasContentIssue false
  • English
  • Français

Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia

Published online by Cambridge University Press:  09 July 2009

J. L. Waddington ,
H. A. Youssef  and
A. Kinsella
J. L. Waddington*
Affiliation:
Royal College of Surgeons in Ireland, Dublin; St Davnet's Hospital, Monaghan; Dublin Institute of Technology, Ireland
H. A. Youssef
Affiliation:
Royal College of Surgeons in Ireland, Dublin; St Davnet's Hospital, Monaghan; Dublin Institute of Technology, Ireland
A. Kinsella
Affiliation:
Royal College of Surgeons in Ireland, Dublin; St Davnet's Hospital, Monaghan; Dublin Institute of Technology, Ireland
*
1Address for correspondence: Professor John L. Waddington, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Current clinical correlates of duration of initially untreated psychotic symptoms were investigated in a cross-sectional analysis followed by a 10-year prospective study among 88 inpatients with a long-standing schizophrenic illness, many of whom had experienced prolonged periods of untreated psychosis due to illness onset and hospital admission in the pre-neuroleptic era. After controlling for the effects of age, and duration and continuity of subsequent neuroleptic treatment, the primary clinical correlate of duration of initially untreated psychosis was muteness. Over the subsequent 10-year-period, no new cases of muteness emerged and some existing cases of muteness partially resolved, though the speech that emerged remained very sparse and revealed generally gross cognitive debility. The pathophysiology underlying active, unchecked psychosis may also constitute an active morbid process that is associated with the further progression of severe negative symptoms and cognitive dysfunction in the long-term.

Type
Original Articles
Information
Psychological Medicine , Volume 25 , Issue 4 , July 1995 , pp. 849 - 857
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abrahamson, D. (1993). Institutionalisation and the long-term course schizophrenia. British Journal of Psychiatry 162, 533–538.CrossRefGoogle Scholar
Altshuler, L. L., Cummings, J. L. & Mills, M. J. (1986). Mutism: review, differential diagnosis, and report of 22 cases. American Journal of Psychiatry 143, 1409–1414.Google Scholar
Andreasen, N. C. (1982). Negative symptoms in schizophrenia. Archives of General Psychiatry 39, 784–788.CrossRefGoogle ScholarPubMed
Andreasen, N. C. & Flaum, M. (1991). Schizophrenia: the characteristic symptoms. Schizophrenia Bulletin 17, 27–49.CrossRefGoogle ScholarPubMed
Andreasen, N. C., Flaum, M., Swayze, V. W., Tyrrell, G. & Arndt, S. (1990). Positive and negative symptoms in schizophrenia: a critical reappraisal. Archives of General Psychiatry 47, 615–621.CrossRefGoogle ScholarPubMed
Baldessarini, R. J. (1985). Chemotherapy in Psychiatry. Harvard University Press: Cambridge.Google Scholar
Benes, F. M. (1993). Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophrenia Bulletin 19, 537–549.CrossRefGoogle ScholarPubMed
Bleuler, M. (1978). The Schizophrenic Disorders: Long-term Patient and Family Studies. (Translated by Clemens, S. M..) Yale University Press: New Haven.Google Scholar
Bogerts, B. (1993). Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin 19, 431–445.CrossRefGoogle ScholarPubMed
Breier, A., Schreiber, J. L., Dyer, J. & Pickar, D. (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry 48, 239–246.CrossRefGoogle ScholarPubMed
Carone, B. J., Harrow, M. & Westermeyer, J. F. (1991). Posthospital course and outcome in schizophrenia. Archives of General Psychiatry 48, 247–253.CrossRefGoogle ScholarPubMed
Ciompi, L. (1980). The natural history of schizophrenia in the long term. British Journal of Psychiatry 136, 413–420.CrossRefGoogle ScholarPubMed
Crow, T. J. & Stevens, M. (1978). Age disorientation in chronic schizophrenia: the nature of the cognitive deficit. British Journal of Psychiatry 133, 137–142.CrossRefGoogle ScholarPubMed
Crow, T. J., Macmillan, J. F., Johnson, A. L. & Johnstone, E. C. (1986). A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 148, 120–127.CrossRefGoogle ScholarPubMed
Davis, J. M. (1976). Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 33, 858–861.CrossRefGoogle ScholarPubMed
Davis, J. M. & Andriukaitis, S. (1986). The natural course of schizophrenia and effective maintenance drug treatment. Journal Clinical Psychopharmacology 6 (suppl.), 2S–10S.CrossRefGoogle ScholarPubMed
Degreef, G., Ashtari, M., Bogerts, B., Bilder, R. M., Jody, D. N., Alvir, J., Ma, J. & Lieberman, J. A. (1992). Volumes of ventricular system subdivisions measured from magnetic resonance images in first episode schizophrenic patients. Archives of General Psychiatry 49, 531–537.CrossRefGoogle ScholarPubMed
DeLisi, L. E. & Lieberman, J. A. (1991). Longitudinal perspectives on the pathophysiology of schizophrenia: examining the neurodevelopmental versus neurodegenerative hypotheses. Schizophrenia Research 5, 183–210.CrossRefGoogle Scholar
DeLisi, L. E., Stritzke, P., Riordan, H., Holan, V., Boccio, A., Kusher, M., McClelland, J., Van Exl, O. & Anand, A. (1992). The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry 31, 241–254.CrossRefGoogle ScholarPubMed
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A. & Winokur, G. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57–63.CrossRefGoogle ScholarPubMed
Fenton, W. S. & McGlashan, T. H. (1991). Natural history schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry 48, 969–977.CrossRefGoogle ScholarPubMed
Fenton, W. S. & McGlashan, T. H. (1992). Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry 49, 179–184.CrossRefGoogle ScholarPubMed
Fostl, H., Besthorn, C., Geiger-Kabisch, C., Sattel, H. & Schreiter-Gasser, U. (1993). Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerised tomography findings. Acta Psychiatrica Scandinavica 87, 395–399.CrossRefGoogle Scholar
Harding, C. M., Brooks, G. W., Ashikaga, T., Strauss, J. S. & Breier, A. (1987). The Vermont longitudinal study of persons with severe mental illness, II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 144, 727–735.Google ScholarPubMed
Harding, C. M., Zubin, J. & Strauss, J. S. (1992). Chronicity in schizophrenia: revisited. British Journal of Psychiatry 161 (suppl. 18). 27–37.CrossRefGoogle Scholar
Hare, E. H. (1974). The changing content of psychiatric illness. Journal of Psychosomatic Research 18, 283–289.CrossRefGoogle ScholarPubMed
Harrison, G. & Mason, P. (1993). Schizophrenia – falling incidence and better outcome? British Journal of Psychiatry 163, 535–541.CrossRefGoogle ScholarPubMed
Iager, A. C., Kirch, D. G. & Wyatt, R. J. (1985). A negative symptom rating scale. Psychiatry Research 16, 27–36.CrossRefGoogle ScholarPubMed
Johnson, J. (1993). Catatonia: the tension insanity. British Journal of Psychiatry 162, 733–738.CrossRefGoogle ScholarPubMed
Kane, J. M. & Lieberman, J. A. (1987). Maintenance pharmacotherapy in schizophrenia. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H. Y.), pp. 1103–1109. Raven Press: New York.Google Scholar
Kelley, M. E., Gilbertson, M., Mouton, A. & van Kammen, D. P. (1992). Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry 149, 1543–1548.Google ScholarPubMed
Kirkpatrick, B., Buchanan, R. W., McKenney, P. D., Alphs, L. D. & Carpenter, W. T. (1989). The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Research 30, 119–123.CrossRefGoogle ScholarPubMed
Kleist, K. (1960). Schizophrenic symptoms and cerebral pathology. Journal of Mental Science 106, 246–253.CrossRefGoogle ScholarPubMed
Kraepelin, E. (1919). Dementia Praecox and Paraphrenia. (Translated by Barclay, R. M..) Livingstone: Edinburgh.Google Scholar
Krawiecka, M., Goldberg, D. & Vaughan, M. (1977). A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica 55, 299–308.CrossRefGoogle ScholarPubMed
Leonhard, K. (1961). The cycloid psychoses. Journal of Mental Science 107, 633–648.CrossRefGoogle ScholarPubMed
Loebel, M. D., Lieberman, J. A., Alvir, J. M. J., Mayerhoff, D. I., Geisler, S. H. & Szymanski, S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal Psychiatry 149, 1183–1188.Google ScholarPubMed
McEvoy, J. P., Schooler, N. R. & Wilson, W. H. (1991). Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacology Bulletin 27, 97–101.Google ScholarPubMed
McGlashan, T. H. & Fenton, W. S. (1992). The positive–negative distinction in schizophrenia: review of natural history validators. Archives of General Psychiatry 49, 63–72.CrossRefGoogle ScholarPubMed
McGlashan, T. H. & Fenton, W. S. (1993). Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin 19, 71–84.CrossRefGoogle ScholarPubMed
Mahendra, B. (1981). Where have all the catatonics gone? Psychological Medicine 11, 669–671.CrossRefGoogle ScholarPubMed
Manschreck, T. C., Maher, B. A., Rucklos, M. E. & Vereen, D. R. (1982). Disturbed voluntary motor activity in schizophrenic disorder. Psychological Medicine 12, 73–84.CrossRefGoogle ScholarPubMed
Morrison, J. R. (1974). Changes in subtype diagnosis of schizophrenia. American Journal of Psychiatry 131, 674–677.CrossRefGoogle ScholarPubMed
Mortimer, A. M., Lund, C. E. & McKenna, P. J. (1990). The positive: negative dichotomy in schizophrenia. British Journal of Psychiatry 157, 41–49.CrossRefGoogle ScholarPubMed
Murray, R. M. & Lewis, S. W. (1987). Is schizophrenia a ncurodevelopmental disorder? British Medical Journal 295, 681–682.CrossRefGoogle ScholarPubMed
O'Callaghan, E., Buckley, P., Redmond, O., Stack, J., Ennis, J. T., Larkin, C. & Waddington, J. L. (1992). Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis. Journal of the Royal Society of Medicine 85, 227–231.CrossRefGoogle Scholar
Qureshi, K. N. & Hodkinson, H. M. (1974). Evaluation of a ten-question mental test in the institutionalised elderly. Age and Ageing 3, 152–157.CrossRefGoogle Scholar
Raskìn, A., Pelchat, R., Sood, R., Alphs, L. D. & Levine, J. (1993). Negative symptom assessment of chronic schizophrenia patients. Schizophrenia Bulletin 19, 627–635.CrossRefGoogle ScholarPubMed
Tune, L. E, Wong, D. F., Pearlson, G., Strauss, M., Young, T., Shaya, E. K., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sapp, J., Cooper, T., Chase, G. A. & Wagner, H. N. (1993). Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone. Psychiatry Research 49, 219–237.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1993 a). Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531–536.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1993 b). Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia. Schizophrenia Bulletin 19, 55–69.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1995). The clinical psychopharmacology of antipsychotic drugs in schizophrenia. In Schizophrenia (ed. Hirsch, S. R. and Weinberger, D. R.), pp. 341–357. Blackwell: Oxford.Google ScholarPubMed
Waddington, J. L. & Youssef, H. A. (1986 a). An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry 143, 1162–1165.Google ScholarPubMed
Waddington, J. L. & Youssef, H. A. (1986 b). Late-onset involuntary movements in chronic schizophrenia: relationship of tardive dyskinesia to intellectual impairment and negative symptoms. British Journal of Psychiatry 149, 616–620.CrossRefGoogle ScholarPubMed
Waddington, J. L., Youssef, H. A., Dolphin, C. & Kinsella, A. (1987). Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 44, 907–912.CrossRefGoogle ScholarPubMed
Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660–669.CrossRefGoogle ScholarPubMed
Wing, J. K. & Brown, G. W. (1970). Institutionalism and Schizophrenia. Cambridge University Press: Cambridge.CrossRefGoogle Scholar
Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17, 325–351.CrossRefGoogle ScholarPubMed
Zubin, J., Magaziner, J. & Steinhauer, S. R. (1983). The metamorphosis of schizophrenia: from chronicity to vulnerability. Psychological Medicine 13, 551–571.CrossRefGoogle ScholarPubMed